Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A

Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A

Specific radioligands for in vivo visualization and quantification of cyclic nucleotide phosphodiesterase 2A (PDE2A) by positron emission tomography (PET) are increasingly gaining interest in brain research. Herein we describe the synthesis, the 18F-labelling as well as the biological evaluation of...

Full description

Bibliographic Details
Main Authors:	Susann Schröder, Barbara Wenzel, Winnie Deuther-Conrad, Rodrigo Teodoro, Mathias Kranz, Matthias Scheunemann, Ute Egerland, Norbert Höfgen, Detlef Briel, Jörg Steinbach, Peter Brust
Format:	Article
Language:	English
Published:	MDPI AG 2018-03-01
Series:	Molecules
Subjects:	Phosphodiesterase 2A (PDE2A) secondary messengers PDE2A radioligands positron emission tomography (PET) neuroimaging metabolic stability micellar liquid chromatography (MLC)
Online Access:	http://www.mdpi.com/1420-3049/23/3/556

Similar Items

Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
by: Susann Schröder, et al.
Published: (2015-05-01)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
by: Susann Schröder, et al.
Published: (2016-05-01)

Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016
by: Susann Schröder, et al.
Published: (2021-04-01)

Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
by: Rien Ritawidya, et al.
Published: (2019-11-01)

Genetic Association of Phosphodiesterases With Human Cognitive Performance
by: Mark E. Gurney
Published: (2019-02-01)

Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[<i>e</i>]imidazo[2,1-<i>c</i>][1,2,4]triazines as Phosphodiesterase 2A Inhibitors
by: Rien Ritawidya, et al.
Published: (2019-07-01)

Clinical Implication of Phosphodiesterase-4-Inhibition
by: Martin Alexander Schick, et al.
Published: (2022-01-01)

Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
by: Barbara Wenzel, et al.
Published: (2022-10-01)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
by: Jianrong Liu, et al.
Published: (2016-04-01)

Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET
by: Detlef Briel, et al.
Published: (2012-02-01)

Phosphodiesterase 1b (PDE1B) Regulates Spatial and Contextual Memory in Hippocampus
by: Susan McQuown, et al.
Published: (2019-02-01)

A Promising Biomolecule Able to Degrade Neutrophil Extracellular Traps: <i>Cdc</i>PDE, a Rattlesnake Phosphodiesterase
by: Isadora Oliveira, et al.
Published: (2023-01-01)

Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma
by: Lin Chen, et al.
Published: (2022-12-01)

Phosphodiesterase 5a Signalling in Skeletal Muscle Pathophysiology
by: Valeria De Arcangelis, et al.
Published: (2022-12-01)

Phosphodiesterase-4 Inhibition in Psoriasis
by: Milakovic M, et al.
Published: (2021-03-01)

Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
by: Marianna Szczypka
Published: (2020-08-01)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01)

Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic‐like effects without affecting cognitive enhancement and cataleptic effects in rats
by: Keita Arakawa, et al.
Published: (2020-06-01)

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation
by: Marie Bielenberg, et al.
Published: (2024-03-01)

Phosphodiesterase 4B: Master Regulator of Brain Signaling
by: Amy J. Tibbo, et al.
Published: (2020-05-01)

Characterization and Modification of Light-Sensitive Phosphodiesterases from Choanoflagellates
by: Yuehui Tian, et al.
Published: (2022-01-01)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
by: Juraj Mokry, et al.
Published: (2021-04-01)

PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells
by: Amy M. Chinn, et al.
Published: (2022-03-01)

Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
by: Rahul Mittal, et al.
Published: (2017-11-01)

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
by: Laura Ponsaerts, et al.
Published: (2021-06-01)

Differential expression and function of PDE8 and PDE4 in effector T cells: Implications for PDE8 as a drug target in inflammation.
by: Amanda G. Vang, et al.
Published: (2016-08-01)

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
by: Andrey D. Bondarev, et al.
Published: (2022-11-01)

Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
by: John F. Harms, et al.
Published: (2019-08-01)

Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential
by: William J. Moss, et al.
Published: (2024-02-01)

Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
by: Zainab Sabri Abbas, et al.
Published: (2021-12-01)

A tandem motif-based and structural approach can identify hidden functional phosphodiesterases
by: Mateusz Kwiatkowski, et al.
Published: (2021-01-01)

Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8)
by: Chaitali P. Basole, et al.
Published: (2022-02-01)

Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling
by: Serena Galosi, et al.
Published: (2022-08-01)

Underlying mechanisms of phosphodiesterase 10A and glutamate-ammonia ligase genes that regulate inosine monophosphate deposition and thereby affect muscle tenderness in Jingyuan chickens
by: Weizhen Wang, et al.
Published: (2022-11-01)

Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity
by: Nikhil K. Tulsian, et al.
Published: (2021-05-01)

Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
by: Alessandro Leuti, et al.
Published: (2013-04-01)

Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
by: Federica Ragusa, et al.
Published: (2021-05-01)

cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor
by: Federica Campolo, et al.
Published: (2022-10-01)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
by: Artem Ovchinnikov, et al.
Published: (2022-08-01)

Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer
by: Tasmina Ferdous Susmi, et al.
Published: (2021-05-01)